Oral antivirals may cut risk of poor outcomes in high-risk patients infected with COVID JN.1
Oral antiviral drugs significantly lowered the risk of adverse outcomes in high-risk COVID-19 patients during the Omicron JN.1 subvariant wave ...
Oral antiviral drugs significantly lowered the risk of adverse outcomes in high-risk COVID-19 patients during the Omicron JN.1 subvariant wave ...
Visual Generation / iStock The "Make Our Children Healthy Again" report issued yesterday by the Make America Healthy Again (MAHA) ...
The Food and Drug Administration’s advisory committee unanimously recommended that newest vaccines for Covid should be updated to target a ...
The Food and Drug Administration (FDA) vaccine advisory group today recommended sticking with a monovalent JN.1 lineage vaccine for COVID ...
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon ...
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon ...
Vinay Prasad, an oncologist and hematologist who has called for more regulatory scrutiny of pharmaceuticals, including Covid vaccines, was named ...
Early in the covid-19 pandemic, the failure of UK government advisers to follow World Health Organization (WHO) advice and emerging ...
President Donald Trump's newly announced nominee for US Surgeon General, Dr. Casey Means, is facing backlash from within the MAGA ...
A proponent of using the drug hydroxychloroquine to treat Covid-19 despite scant evidence of its efficacy has been named to ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.